top of page

Journal: Clinics and Research in Hepatology and Gastroenterology

First author: Rim Bourguiba

Country of study: France and Tunisia

CEREMAIA Tenon author(s): Marion Delplanque, Catherine Grandpeix-Guyodo, Léa Savey, Sophie Georgin-Lavialle

Reference: Bourguiba R, Delplanque M, Grandpeix-Guyodo C, Boursier G, Savey L, Cuisset L, Georgin-Lavialle S. When to suspect monogenic autoinflammatory diseases in patients with digestive symptoms? Clinics and Research in Hepatology and Gastroenterology. 2026;50:102820.

DOI: https://doi.org/10.1016/j.clinre.2026.102820


When to suspect monogenic autoinflammatory diseases in patients with digestive symptoms?

5 key points:

  • Some rare autoinflammatory diseases can cause abdominal pain, diarrhoea, digestive inflammation or symptoms that resemble inflammatory bowel disease.

  • Familial Mediterranean fever is the most common monogenic autoinflammatory disease and should be considered in people of Mediterranean origin with repeated inflammatory abdominal pain.

  • Associated signs such as recurrent fever, mouth ulcers, skin rashes, joint pain, macrocytic anaemia or family history should raise suspicion of an autoinflammatory cause.

  • Diagnosis is based on clinical assessment, inflammation markers, sometimes IL-18 measurement, and appropriate genetic testing.

  • Earlier diagnosis can reduce diagnostic delay, guide treatment and help prevent complications such as AA amyloidosis.


Introduction

Systemic autoinflammatory diseases are rare conditions caused by abnormal activation of the innate immune system, the body’s first line of defence. They can cause flares of inflammation with fever, pain, skin involvement, joint symptoms or digestive problems. In some patients, digestive symptoms are the main feature and may look like inflammatory bowel disease, such as Crohn’s disease.


Methods

This article is a narrative review of the medical literature. The authors describe the main monogenic autoinflammatory diseases that may cause digestive symptoms and highlight situations in which gastroenterologists should consider these diagnoses.


Results

Several diseases can cause abdominal pain, diarrhoea, colitis, digestive ulcers or inflammation that resembles Crohn’s disease. Familial Mediterranean fever is the most common, especially in people of Mediterranean origin. Other conditions include TRAPS, Mevalonate kinase deficiency, cryopyrin-associated diseases, VEXAS syndrome, A20 haploinsufficiency, and diseases linked to RIPK1, RELA, NFKB1, JAK1, STAT, PSTPIP1, ADA2, LACC1, XIAP or PLCG2. Warning signs include recurrent fever, unexplained inflammation in blood tests, mouth ulcers, skin rashes, joint pain, family history, Mediterranean origin, macrocytic anaemia or poor response to usual treatments for inflammatory digestive diseases.


Discussion

The article emphasizes that not all digestive inflammation should automatically be considered a typical bowel disease. An autoinflammatory disease may mimic inflammatory bowel disease, coexist with it, or be revealed by unusual digestive symptoms. Useful investigations may include inflammation markers, endoscopy, specific biomarkers such as IL-18, and above all appropriate genetic testing, ideally discussed with expert centres.


Conclusion

Rare autoinflammatory diseases should be considered when digestive symptoms are inflammatory, unexplained, recurrent or resistant to usual treatments. Early diagnosis can lead to more appropriate care, often using treatments that target inflammation, and may help prevent complications such as AA amyloidosis.


 
 
 

First author: Yvan Jamilloux

Country of study: France

CEREMAIA Tenon author: Sophie Georgin-Lavialle

Reference: Jamilloux Y, André M, Maillard H, Baudet M, Beauvais F, Boursier G, Buschiazzo A, Donal E, Flecher E, Georgin-Lavialle S, Gerfaud-Valentin M, Kone-Paut I, Labombarda F, Piriou N, Saadoun D, Aouba A, and collaborators. French protocol for the diagnosis and management of recurrent pericarditis / Protocole national de diagnostic et de soins – Péricardites récidivantes. La Revue de médecine interne. 2026;47:127–146.

DOI: https://doi.org/10.1016/j.revmed.2026.02.002


French protocol for the diagnosis and management of recurrent pericarditis  Journal: La Revue de médecine interne

5 key points

  • Recurrent pericarditis means repeated episodes of inflammation of the pericardium, separated by a symptom-free period of at least 4 to 6 weeks.

  • Diagnosis is based on symptoms, clinical examination, electrocardiogram, echocardiography, sometimes cardiac MRI, and inflammation markers such as CRP.

  • Colchicine is the cornerstone treatment to reduce the risk of recurrence and is often combined with anti-inflammatory drugs during flares.

  • Corticosteroids should be avoided as much as possible, except in specific situations, because they may promote treatment dependence and recurrences.

  • In severe or resistant forms, treatments targeting interleukin-1, such as anakinra, may be discussed with expert centres.


Introduction

Pericarditis is inflammation of the pericardium, the thin sac surrounding the heart. When it comes back several times after a first episode, it is called recurrent pericarditis. This condition can cause significant chest pain, anxiety, emergency visits and difficulties in family, social or professional life.


Methods

This article is a French national protocol for diagnosis and care. It brings together expert recommendations to help physicians diagnose, treat and follow people with recurrent pericarditis, including adults, children and specific situations such as pregnancy.


Results

Diagnosis relies on several elements: typical chest pain, a pericardial rub heard during examination, electrocardiogram changes, fluid around the heart on echocardiography, and blood signs of inflammation, especially CRP. Cardiac MRI can help in difficult cases. Most cases are called idiopathic, often presumed to follow a viral infection, but some may be linked to autoimmune, autoinflammatory or infectious diseases, or to inflammation after cardiac surgery or procedures. Serious complications, such as cardiac tamponade or constrictive pericarditis, are rare but must be recognized quickly.


Discussion

Treatment aims to control inflammation, relieve pain and, above all, prevent recurrences. Colchicine is central and often needs to be continued for several months. During flares, anti-inflammatory drugs or aspirin may be used together with colchicine. Corticosteroids are no longer recommended except in specific cases. In severe, resistant or corticosteroid-dependent forms, interleukin-1 inhibitors, particularly anakinra, can improve symptoms and quality of life. Follow-up should also include rest, gradual return to physical activity, patient education and attention to psychological impact.


Conclusion

Recurrent pericarditis requires coordinated care involving cardiologists, internal medicine specialists, general practitioners and expert centres. Accurate diagnosis, appropriate treatment and very gradual treatment withdrawal can reduce relapses and improve quality of life.

 
 
 

Journal: La Revue de médecine interne

First author: Pierre Quartier

Country of study: France

CEREMAIA Tenon author: Sophie Georgin-Lavialle

Reference: Quartier P, Belot A, Breton S, Carbasse A, Devauchelle V, Fautrel B, Georgin-Lavialle S, Jurquet A-L, Koné-Paut I, Lemelle I, Meinzer U, Melki I, Pillet P, Reumaux H, Rossi-Semerano L, Uettwiller F, and collaborators. French protocol for the diagnosis and management of juvenile idiopathic arthritis including pediatric-onset Still’s disease / Protocole national de diagnostic et de soins pour l’arthrite juvénile. La Revue de médecine interne. 2025;46:449–481.

DOI: https://doi.org/10.1016/j.revmed.2025.06.001


French protocol for the diagnosis and management of juvenile idiopathic arthritis including pediatric-onset Still’s disease

5 key points:

  • Juvenile idiopathic arthritis starts before the age of 16 and causes joint inflammation lasting at least 6 weeks without another identified cause.

  • Early diagnosis by a paediatric rheumatologist is essential to reduce pain, joint complications and unnecessary investigations.

  • Some forms require regular screening for uveitis, an eye inflammation that may be silent but potentially serious.

  • Care aims for inactive disease or remission through tailored treatments that are regularly reassessed.

  • The systemic form, also called pediatric-onset Still’s disease, can be severe and requires rapid care in an expert centre.


Introduction:

Juvenile idiopathic arthritis, or JIA, is the main chronic inflammatory rheumatic disease in children. It starts before the age of 16 and causes one or more swollen, painful or stiff joints, especially in the morning or at night. In France, around 5,000 children under 16 are thought to be affected.


Methods:

This article is a French national protocol for diagnosis and care. It brings together updated French recommendations to help healthcare professionals diagnose, treat and follow children with JIA, including the systemic form known as pediatric-onset Still’s disease.


Results:

JIA includes several forms: oligoarthritis, polyarthritis, enthesitis-related forms, psoriasis-associated forms, undifferentiated forms and systemic disease. Diagnosis is based on clinical examination, symptom duration, blood tests, imaging when needed, and exclusion of other causes such as infection. Children also need eye follow-up, because some forms can cause uveitis, an eye inflammation that may have no visible symptoms. Treatments include anti-inflammatory drugs, joint injections, methotrexate, biologic therapies and, in some cases, JAK inhibitors. For pediatric Still’s disease, treatments targeting interleukin-1 or interleukin-6 may be used early.


Discussion:

The article emphasizes a “treat-to-target” strategy, meaning treatment is guided by a clear goal: quickly control inflammation, prevent long-term damage and, if possible, achieve inactive disease or remission. Care must be multidisciplinary, involving a paediatric rheumatologist, general practitioner, ophthalmologist, physiotherapist, occupational therapist, psychologist, nurse, school and family. Therapeutic education helps children and parents understand the disease, recognize flares, manage treatments and maintain life as normally as possible.


Conclusion:

JIA requires early diagnosis, regular follow-up and strong coordination between families and expert teams. Advances in treatment now make it possible to better control inflammation, reduce complications and improve children’s quality of life.


 
 
 
bottom of page